Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
General Rheumatology
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Related Questions
Do you always get a baseline chest xray in patients who will be starting methotrexate?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
